Tags : Biosolution

Mundipharma Signs an Exclusive Commercialization and Distribution Agreement with Biosolution

Shots: Mundipharma to get exclusive rights to market and distribute Biosolution’s CartiLife in South Korea. In May 2016, the companies signed commercialization agreement for allogeneic keratinocyte cell therapy product, KeraHeal-Allo and is the second agreement signed presently The focus of the agreement is to include Biosolution’s CartiLife in the Mundipharma’s portfolio of orthopedic care CartiLife […]Read More